These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11684751)

  • 61. Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness.
    Woltmann EM; Valenstein M; Welsh DE; Lee TA; Wolschon PA; Grabowski J; Reilly PA
    Psychiatr Serv; 2007 Jun; 58(6):864-7. PubMed ID: 17535949
    [TBL] [Abstract][Full Text] [Related]  

  • 62. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics.
    Baser O; Xie L; Pesa J; Durkin M
    J Med Econ; 2015 May; 18(5):357-65. PubMed ID: 25525771
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of clozapine on polypharmacy.
    Chong SA; Remington GJ; Bezchlibnyk-Butler KZ
    Psychiatr Serv; 2000 Feb; 51(2):250-2. PubMed ID: 10655014
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Benzodiazepine prescribing variation and clinical uncertainty in treating posttraumatic stress disorder.
    Lund BC; Abrams TE; Bernardy NC; Alexander B; Friedman MJ
    Psychiatr Serv; 2013 Jan; 64(1):21-7. PubMed ID: 23070039
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Variations in use of second-generation antipsychotic medication by race among adult psychiatric patients.
    Herbeck DM; West JC; Ruditis I; Duffy FF; Fitek DJ; Bell CC; Snowden LR
    Psychiatr Serv; 2004 Jun; 55(6):677-84. PubMed ID: 15175466
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.
    Harris AH; Oliva E; Bowe T; Humphreys KN; Kivlahan DR; Trafton JA
    Psychiatr Serv; 2012 Jul; 63(7):679-85. PubMed ID: 22549276
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinic visits and prescribing patterns among Veterans Affairs Maryland Health Care System dementia patients.
    Rattinger GB; Mullins CD; Zuckerman IH; Onukwugha E; Delisle S
    J Nutr Health Aging; 2010 Oct; 14(8):677-83. PubMed ID: 20922345
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of electronic medical record data for quality improvement in schizophrenia treatment.
    Owen RR; Thrush CR; Cannon D; Sloan KL; Curran G; Hudson T; Austen M; Ritchie M
    J Am Med Inform Assoc; 2004; 11(5):351-7. PubMed ID: 15187073
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Industry-sponsored grand rounds and prescribing behavior.
    Dieperink ME; Drogemuller L
    JAMA; 2001 Mar; 285(11):1443-4. PubMed ID: 11255418
    [No Abstract]   [Full Text] [Related]  

  • 71. Organizational Characteristics of Veterans Affairs Clinics With High and Low Utilization of Clozapine.
    Gören JL; Rose AJ; Engle RL; Smith EG; Christopher ML; Rickles NM; Semla TP; McCullough MB
    Psychiatr Serv; 2016 Nov; 67(11):1189-1196. PubMed ID: 27301765
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Psychiatrists' self-reported adherence to evidence-based prescribing practices in the treatment of schizophrenia.
    Young GJ; Mohr DC; Meterko M; Seibert MN; McGlynn G
    Psychiatr Serv; 2006 Jan; 57(1):130-2. PubMed ID: 16399975
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prescription of second-generation antipsychotics: responding to treatment risk in real-world practice.
    Hermes ED; Sernyak MJ; Rosenheck RA
    Psychiatr Serv; 2013 Mar; 64(3):238-44. PubMed ID: 23241613
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of legislative changes on patterns of antipsychotic prescribing and self-poisoning in Scotland: 2000-06.
    Poon H; Elliot V; Bateman DN; Waring WS
    J Toxicol Sci; 2007 Feb; 32(1):1-7. PubMed ID: 17327689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The heterogeneity of concentrated prescribing behavior: Theory and evidence from antipsychotics.
    Berndt ER; Gibbons RS; Kolotilin A; Taub AL
    J Health Econ; 2015 Mar; 40():26-39. PubMed ID: 25575344
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antipsychotic medication utilization in nonpsychiatric hospitalizations.
    Herzig SJ; Rothberg MB; Guess JR; Gurwitz JH; Marcantonio ER
    J Hosp Med; 2016 Aug; 11(8):543-9. PubMed ID: 27130311
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Racial disparity in the pharmacological management of schizophrenia.
    Kreyenbuhl J; Zito JM; Buchanan RW; Soeken KL; Lehman AF
    Schizophr Bull; 2003; 29(2):183-93. PubMed ID: 14552495
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles.
    Covell NH; Jackson CT; Evans AC; Essock SM
    Schizophr Bull; 2002; 28(1):17-29. PubMed ID: 12047017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Facility-level variation in potentially inappropriate prescribing for older veterans.
    Gellad WF; Good CB; Amuan ME; Marcum ZA; Hanlon JT; Pugh MJ
    J Am Geriatr Soc; 2012 Jul; 60(7):1222-9. PubMed ID: 22726206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.
    Hudson TJ; Owen RR; Thrush CR; Armitage TL; Thapa P
    J Clin Psychiatry; 2008 Jan; 69(1):74-80. PubMed ID: 18312040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.